RenovoRx, Inc.(RNXT)Earnings, Financials & Key RatiosRenovoRx, Inc. (RNXT) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's reliance on non-recurring revenue and a persistent quarterly cash burn exceeding $2 million suggests a high probability of near-term equity dilution.
RenovoRx, Inc. (RNXT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Recent stock market news and headlines for RenovoRx, Inc. (RNXT)
RenovoRx, Inc. (RNXT) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Transcript
Key metrics vs top competitors for RenovoRx, Inc. (RNXT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.93 | $35.28M | -2.90 | 2511.63% | -994.48% | -225.62% | — | |
| $74.90 | $1.46B | -7.70 | -43.89% | -284.18% | -87% | — | |
| $5.29 | $10.32M | -0.46 | -13.43% | -299.66% | — | — | |
| $4.75 | $192.85M | 3.89 | 36.55% | -19.55% | -3.39% | — | |
| $40.09 | $8.23B | -14.47 | — | — | -68.16% | — | |
| $0.15 | $2.33M | -0.06 | -15.77% | -183.93% | — | — |
RenovoRx, Inc. (RNXT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
RenovoRx, Inc. (RNXT) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 14, 2026·SEC
Mar 30, 2026·SEC
Mar 27, 2026·SEC
Get notified when RNXT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
RenovoRx, Inc. (RNXT) stock FAQ — growth, dividends, profitability & financials explained
RenovoRx, Inc. (RNXT) reported $1.5M in revenue for fiscal year 2025.
RenovoRx, Inc. (RNXT) grew revenue by 2511.6% over the past year. This is strong growth.
RenovoRx, Inc. (RNXT) reported a net loss of $12.3M for fiscal year 2025.
RenovoRx, Inc. (RNXT) has a return on equity (ROE) of -225.6%. Negative ROE indicates the company is unprofitable.
RenovoRx, Inc. (RNXT) had negative free cash flow of $11.3M in fiscal year 2025, likely due to heavy capital investments.
